BW

Global Coalition for Adaptive Research Announces Key Updates on GBM AGILE Phase 2-3 Adaptive Platform Trial for Patients With Glioblastoma

Trial Reaches Milestone of Over 1000 Patients Screened Addition of New Interventions – Biohaven Pharmaceuticals’ Troriluzole and Vigeo Therapeutics’ VT1021 Planned Expansion of Trial to Include Sites in Europe and China LOS ANGELES--(BUSINESS WIRE)--Global Coalition for Adaptive Research (GCAR) today announced an update on the progress of GBM AGILE (Glioblastoma…
Leer más...

Equity Commonwealth Announces Tax Treatment of 2021 Distributions

CHICAGO--(BUSINESS WIRE)--Equity Commonwealth (NYSE: EQC) today announced the tax treatment of its 2021 preferred share distributions, which is as follows: Series D Cumulative Convertible Preferred Stock (CUSIP No. 294628201) Record Date Payment Date Total Distribution per Share 2021 Non-taxable Distribution (Return of Capital) 1/28/2021 2/16/21 $ 0.406250 $ 0.406250 4/29/21…
Leer más...

Metalmark Announces New Strategic Investment Fund to Support Continued Growth of Innovetive Petcare, a Leading Veterinary Services Provider

Metalmark commits additional capital with dedicated fund to help drive long-term value NEW YORK & AUSTIN, Texas--(BUSINESS WIRE)--Metalmark Capital (“Metalmark”), a leading private equity firm, announced that it has raised new capital to support the continued growth of Innovetive Petcare (“Innovetive” or the “Company”). The continuation fund broadens and strengthens…
Leer más...

OFS Credit Company Provides December 2021 Net Asset Value Update

CHICAGO--(BUSINESS WIRE)--OFS Credit Company, Inc. (NASDAQ: OCCI) (“OFS Credit,” the “Company,” “we,” “us” or “our”), an investment company that primarily invests in collateralized loan obligation (“CLO”) equity and debt securities, today announced the following net asset value (“NAV”) estimate as of December 31, 2021. Management’s unaudited estimate of the range…
Leer más...

Hancock Whitney Reports Fourth Quarter 2021 EPS of $1.55

A Strong Finish to a Record Year; 2021 EPS totaled $5.22 GULFPORT, Miss.--(BUSINESS WIRE)--Hancock Whitney Corporation (Nasdaq: HWC) today announced its financial results for the fourth quarter of 2021. Net income for the fourth quarter of 2021 totaled $137.7 million, or $1.55 per diluted common share (EPS), compared to $129.6…
Leer más...